Insilico Medicine
Cambridge · Founded 2014
About Insilico Medicine
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Company Facts
- Founded: 2014
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $624.3M
- Funding stage: IPO
- Last round: Series E (Mar 2025)
- Ticker: hkg:3696
- Website: http://www.insilico.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/insilico-medicine-58956 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.